Background And Objective: To assess the effect of laser fluence reduction to reduce pain during panretinal photocoagulation.
Patients And Methods: Twenty-five patients (50 eyes) with diabetic retinopathy who had indication for panretinal photocoagulation were included in this prospective, interventional, and comparative study. The right eyes were treated using low fluence parameters (LFP), whereas the left eyes were treated with standard fluence parameters (SFP). At the end of each session, the patient was asked to rate pain from 0 (no pain) to 10 (maximum pain) for each eye (NRS-11 scale). Fluence per burn and total fluence were determined for each eye. Statistical analysis was performed using the Mann-Whitney U test and the Pearson correlation coefficient.
Results: Pain perception (P < .01) and fluence per burn (P < .01) were significantly less using LFP compared with SFP. Pain was proportional to fluence per burn (R(2) = 0.4), but not to number of burns (R(2) = -0.2).
Conclusion: The use of LFP seems to be a good option to diminish the pain during panretinal photocoagulation.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.3928/15428877-20100525-02 | DOI Listing |
Purpose: This systematic review aims to consolidate key findings regarding the efficacy of pain relief medications administered prior to pan-retinal photocoagulation (PRP) for diabetic retinopathy (DR).
Methods: A comprehensive search of major databases from 1993 to 2023 was conducted. Clinical trials comparing pain relief drugs before PRP in patients diagnosed with DR requiring PRP treatment were eligible for inclusion.
Sisli Etfal Hastan Tip Bul
September 2024
Department of Ophthalmology, University of Health Sciences Türkiye, Basaksehir Cam and Sakura City Hospital, Istanbul, Türkiye.
Objectives: To compare the pain perception and treatment duration in patients undergoing panretinal photocoagulation (PRP) for high-risk proliferative diabetic retinopathy (PDR) using Navilas laser versus conventional laser.
Methods: A study was conducted involving 40 patients with bilateral high-risk PDR. Each patient underwent PRP with conventional laser in one eye and Navilas laser in the other.
Am J Ophthalmol
November 2024
University of Iowa (G.S.D.V.), Iowa City, Iowa, USA.
Purpose: Pan-retinal photocoagulation (PRP) is the mainstay of treatment for proliferative diabetic retinopathy (PDR), reducing the risk of severe vision loss. Pain poses a potential obstacle to effective laser delivery and patient compliance. Therefore, implementing pain relief strategies can enhance both treatment efficacy and patient comfort.
View Article and Find Full Text PDFJ Vitreoretin Dis
February 2024
Department of Ophthalmology, University of California San Francisco, San Francisco, CA, USA.
To report a case of severe eye pain developing during dialysis. A case report was performed. A 41-year-old man with uncontrolled type 2 diabetes and end-stage nephropathy developed severe pain in the left eye during hemodialysis.
View Article and Find Full Text PDFJ Pak Med Assoc
February 2024
Department of Ophthalmology, Gujranwala Medical College, DHQ Teaching Hospital, Gujranwala, Pakistan.
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!